Avoro Capital Advisors LLC Apellis Pharmaceuticals, Inc. Transaction History
Avoro Capital Advisors LLC
- $6.86 Billion
- Q4 2024
A detailed history of Avoro Capital Advisors LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 12,222,222 shares of APLS stock, worth $336 Million. This represents 5.68% of its overall portfolio holdings.
Number of Shares
12,222,222
Previous 11,111,111
10.0%
Holding current value
$336 Million
Previous $320 Million
21.71%
% of portfolio
5.68%
Previous 4.82%
Shares
12 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
123MCall Options Held
2.63MPut Options Held
845K-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$327 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$325 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$276 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$265 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$159 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.02B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...